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Resveratrol (RSV) is a natural compound found in grapes and red wine. It has been well known for its ben-
eﬁcial effects as a dietary supplement in prevention of cardiovascular diseases and cancer. Recently,
in vitro studies have reported the neuroprotective role of RSV in neurodegenerative process in Alzhei-
mer’s disease (AD). However, in vivo effects of RSV on the decline of brain function accompanying the
aging process, especially those on cognitive loss, have not been not investigated. Here we report that,
after intraventricular injection of RSV for one week in 8–9 month-old mice, the long-term memory for-
mation and the LTP induction from hippocampus CA1 were improved. The RSV enhancement effects were
blocked in SIRT1 mutant mice. Additional experiments suggest that RSV effects are likely to be mediated
through reduced expressions of miR-134 and miR-124, which may in turn up-regulate CREB levels to sub-
sequently promote BDNF synthesis. These ﬁndings demonstrate a role for RSV in cognition and a microR-
NA-CREB-BDNF mechanism by which RSV regulates these processes, demonstrating its value as a
potential therapeutic target against CNS disorders in aging.
 2013 The Authors. Published by Elsevier Inc. Open access under CC BY license.1. Introduction
The industrialized world’s population is growing increasingly
older. The physiological process of aging involves a progressive
cognitive loss caused by deterioration of brain function, which
includes a decrease in learning and memory skills and slower re-
sponses to intellectual stimuli. In age-related neuronal disorders,
the free radicals and the oxidative stress they generate are known
as the prime candidates responsible for producing the cell changes
in such diseases [1,2]. The free radical hypothesis of aging has been
utilized to explain the increased incidence of cancer and heart dis-
ease. The brain may be even more vulnerable to oxidative stress, as
it exhibits reduced free radical scavenging ability and utilizes high
amounts of oxygen [3,4]. Recently, a number of studies from thediets rich in fruit and vegetables or herbal extracts that exhibit
anti-oxidant activities have shown some positive effects on reduc-
ing certain types of cancer and cardiovascular diseases [5–7], sug-
gesting that these kinds of dietary modiﬁcations may also be
beneﬁcial in slowing the neuronal/behavioral deﬁcits associated
with aging.
Numerous contents within dietary fruits and vegetables exhibit
anti-aging activities in various systems, among which one compo-
nent resveratrol (RSV) (3,40,5-trihydroxystilbene) is such a promis-
ing candidate [7]. RSV is a dietary polyphenol present in more than
70 different plants, especially in skin of grapes, and is speculated
to be responsible for the ‘‘French Paradox’’ [8,9]. RSV exists in two
isomers: trans- and cis-resveratrol,whichmayhavedifferent biolog-
ical effects. It has been known that trans-resveratrol is nontoxic and
is most widely studied. The number of studies is growing to show
RSV’s various beneﬁcial biological effects, including its antioxidant,
anti-inﬂammatory activities, release of neurotransmitters and neu-
romodulators [10–14]. Moreover, pre-clinical studies have demon-
strated that RSV has the ability to limit the pathological states
associated with cerebral ischemic injury, diabetes, arthritis, and a
number of other aging-associated disorders [15–18]. Mechanisti-
cally, RSV has also been shown to mimic a calorie-restriction diet
that extends lifespan and stress resistance by linking to the longev-
itygeneSilent InformationRegulatorT1 (SIRT1) inyeast,worms, and
ﬂies [19,20]. Recent studies suggest functional relevance of SIRT1
598 Y.-N. Zhao et al. / Biochemical and Biophysical Research Communications 435 (2013) 597–602activity in the brain [21,22]. Activation of SIRT1 is neuroprotective in
a Cdk5model of neurodegeneration [10]. Our previous data showed
that SIRT1 dysfunction contributed to impaired learning and mem-
ory through microRNA-CREB-BDNF pathway [22].
Aging and age-associated neurodegenerative diseases are
accompanied with various degrees of behavioral impairments
including impaired learning and memory. And RSV ameliorated
cognitive decline in Huntington’s disease model mice or senes-
cence-accelerated mice [23–25]. Whether RSV can improve normal
behavior or brain function in a normal, healthy elderly is unknown.
In the present study, we investigated the effect of RSV on learning
and memory through intracerebroventricular injection of RSV into
8–9 month-old mice. And we observed a positive effect of RSV on
memory formation and LTP induction in these aged mice. Further-
more, RSV treatment of cultured hippocampus slices causes reduc-
tion of several CREB-targeting miRNAs and a known CREB target,
BDNF, which is consistent with an increase of CREB protein in hip-
pocampus tissue from RSV-treated mice.
2. Materials and methods
2.1. Mice
Animals were derived from the C57BL/6J strain obtained from
Model Animal Research Center. And the SIRT1Dex4/Nestin-Cre mice
were kindly provided by Dr. Tsai LH (Massachusetts Institute of
Technology, Cambridge, MA). All animal protocols are approved
by the Animal Care and Use Committee of the Model Animal Re-
search Center, the host for the National Resource Center for Mutant
Mice in China, Nanjing University.
2.2. Fear conditioning tests
Training consists of a 3 min exposure of mice to the condition-
ing box (context) followed by a tone [30 s, 20 kHz, 75 dB sound
pressure level (SPL)] and a foot shock (2 s, 0.8 mA, constant cur-
rent). The memory test was performed 24-h later or 48-h by re-
exposing the mice for 3 min into the conditioning context or to a
tone (20 kHz, 75 dB SPL) in a novel context. Freezing, deﬁned as
a lack of movement except for breathing associated with a crouch-
ing posture, was recorded every 10 s by two trained observers (one
was unaware of the experimental conditions) during 3 min (a total
of 18 sampling intervals). The number of observations indicating
freezing obtained as a mean from both observers was expressed
as a percentage of the total number of observations.
2.3. Electrophysiological analysis
The ﬁeld excitatory postsynaptic potentials (ﬁeld EPSP [fEPSP])
from hippocampal CA1 region were recorded as described previ-
ously [22]. Brieﬂy, transverse hippocampal slices (400 lm thick)
were prepared from 8 to 9 month-old male mice. After decapita-
tion, the brain was removed and placed in oxygenated (95% O2/
5% CO2) artiﬁcial cerebrospinal ﬂuid (ACSF) at 4 C. Slices were
cut with a Leica VT1000S vibratome (Leica instruments Ltd., Wetz-
lar, Germany) and maintained at 32 C in a holding chamber ﬁlled
with oxygenated ACSF for 1-h. After an equilibration period of at
least 2 h at room temperature, a single slice was transferred to
the recording chamber, where it was held between two nylon nets
and continuously perfused with oxygenated ACSF (23–25 C) at a
ﬂow rate of 2.5–3 ml/min.
2.4. Cannulation and injections
Double cannulae were implanted 7 days before the experi-
ments, under anesthesia. For resveratrol injection, the cannulaewere placed in lateral brain ventricles, AP-0.5 mm, lateral 1 mm,
depth 2 mm. Resveratrol (5 lg/ll, Sigma) or vehicle was injected
bilaterally for a week using a microinjector (CMA/microdialysis)
over a 1-min period, so that a volume of 0.5 ll was injected into
each side. Resveratrol (25% DMSO/artiﬁcial cerebrospinal ﬂuid)
was prepared fresh immediately before each injection.2.5. Protein extraction and immunoblotting
The hippocampi were collected and lysesed in RIPA buffer. The
lysates were incubated for 15 min on ice and centrifuged for
15 min at 4,000g at 4 C. The supernatant was collected. The
lysates were subjected to 10% SDS–PAGE followed by
immunoblotting.2.6. Taqman miRNA real time qPCR
Total small RNA was extracted using PureLinK miRNA Isolation
Kit (Invitrogen) according to the manufacturer’s instructions. RNA
was reverse-transcribed using speciﬁc miRNA stem-loop primers
and the Taqman microRNA reverse transcription kit (Applied Bio-
systems). Mature miRNA expression was measured with Taqman
microRNA assays (Applied Biosystems) according to the manufac-
turer’s instructions.3. Results
3.1. RSV improves memory formation in mice
To investigate the effect of RSV on learning and memory, mice
were treated by RSV through cerebroventricular injection for
1-week. Firstly, we examined whether the acetylation of PGC-1al-
pha, a known target for SIRT1, was decreased following RSV treat-
ment. Indeed, we observed a decrease in acetylation of PGC-1alpha
in hippocampus (Fig. 1A), suggesting that SIRT1 activity is in-
creased following RSV treatment. Then, we investigated that the
effect of RSV on memory formation. Eight to nine month-old mice
were trained using Pavlovian fear conditioning paradigms prior to
a memory test 24 h later. Mice treated with RSV for 1-week
(n = 10) displayed an increased freezing level in both the context-
and tone-dependent fear learning (Fig. 1B, left and right, respec-
tively) compared with that of the control mice (n = 10). This was
not due to changes in locomotors activity or exploratory behavior
(Fig. 1D). Moreover, in a striking contrast to control mice, RSV did
not enhance freezing behavior in neuron-speciﬁc SIRT1-deﬁcient
mice (SIRT1D) (Fig. 1C), which demonstrates a SIRT1-dependent
mode of action for RSV. As a control, neither RSV nor the status
of SIRT1 affected the shock sensitivity of the mice (Fig. 1D). These
results indicate that RSV acts upon SIRT1 to play a critical regula-
tory role on memory formation in aged mice.3.2. RSV facilitates LTP induction in hippocampus slices
Acutely dissociated hippocampus slices were treated with RSV
for 1-h before and during electrophysiological recording. RSV treat-
ment did not change the fEPSP baseline (Fig. 2A). Input–output
coupling (Fig. 2B) was not signiﬁcantly different between RSV
and Veh mice. However, RSV treatment facilitated an LTP response
from one train of h burst stimulation (1  TBS) in hippocampal
slices prepared from control mice (Fig. 2C). Moreover, RSV did
not facilitate LTP induction in SIRT1D mice (Fig. 2D). These results
demonstrate a SIRT1-dependent mode of action for RSV on synap-
tic plasticity.
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Fig. 1. Resveratrol, a SIRT1 agonist, improves associative learning by targeting SIRT1. (A) Acetylation levels of PGC-1alpha was decreased in animals treated with resveratrol
(RSV, daily ICV injection, 5 lg/lL, 0.5 lL, for 1 week), compared to animals injected with vehicle (Veh). (B) Mice subjected to injection of RSV displayed signiﬁcantly improved
freezing behavior during the contextual and tone-dependent memory test compared to the vehicle group (RSV, n = 10; Veh, n = 10). (C) Freezing behavior was reduced in
SIRT1 mutant (SIRT1D) mice compared with ﬂoxed littermate control (Cont) mice (SIRT1D, n = 10; Cont, n = 10). Moreover, RSV ICV treatment for a week did not display
enhanced freezing behavior in SIRT1D mice, in contrast to control mice (SIRT1D, n = 10; Cont, n = 10). (D) The response to ES at baseline, and after training, did not differ
between control and SIRT1D mice, with and without RSV treatment.
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It has been reported that SIRT1 regulates learning and mem-
ory through miR134 [22]. Thus, we evaluated the expression of
microRNAs using mature miRNA-speciﬁc quantitative PCR (Taq-
Man MicroRNA assay). Consistent with the previor data, our
qPCR analyses conﬁrmed signiﬁcant changes in expression of
miR-134 after hippocampus slices was treated with 5 lM RSV
for 1-h (Fig. 3A). Moreover, the level of miR-124 was also de-
creased after RSV treatment (Fig. 3A). Both of these two microR-
NAs were shown to regulate CREB expression and activity
[26,27]. Thus, we further investigated the effect of RSV on CREB
activity using a luciferase reporter containing CRE-binding ele-
ments in cultured CAD cells. As shown in Fig. 3B, CREB activity
was dose-dependently enhanced by RSV treatment in CAD cells.
Moreover, we observed the toxic effect of RSV on cultured CAD
cells in 50 lM.3.4. RSV treatment increases the expression of CREB and BDNF in
acutely dissociated hippocampus slices
Next, we investigated if RSV regulates the expression of CREB.
As shown in Fig. 4A, the expression level of CREB was signiﬁcantly
increased in hippocampi of mice treated with RSV for 1-week.
Moreover, the level of BDNF, a CREB downstream target, was also
enhanced in RSV treated slices (Fig. 4B). Owing to the importance
of CREB-BDNF axis in cognitive function, our data collectively sug-
gest the role of this functional axis downstream of a previously
identiﬁed SIRT1-miRNA pathway in mediating RSV’s positive effect
on learning and memory in aged mice.4. Discussion
In our study, resveratrol (RSV) signiﬁcantly improved memory
formation and synaptic plasticity compared with the control
8–9 month-old mice treated with Veh. And its effect is SIRT1-
dependant since the latter positive effects of RSV is blocked in
SIRT1 mutant mice. Moreover, after RSV treatment in cultured hip-
pocampi slices, the levels of miR-134 and 124 were downregu-
lated, which accompanied an increase of BDNF. Together with
the data that CREB protein is increased in the hippocampus of
RSV-treated mice, our results collectively suggested that RSV acts
via an age-independent miR-CREB-BDNF pathway to improve
learning and memory and that a RSV-rich diet may be beneﬁcial
for preserving cognitive function by in aged individuals.
Resveratrol is a polyphenol phytoalexin which is synthesized by
various edible plants in response to environmental stress (such as
heavy metal ions) or fungal infection [6]. It has been well known
that RSV has antioxidant, anti-ﬂammatory, cardioprotective and
anti-carcinogenic effects [5,7,11]. Moreover, RSV has been recently
shown neuroprotective effects. For example, RSV administration
has been effective in reducing damage in a number of cell cultures
and animal models of central nervous system ischemia, diminish-
ing the toxicity induced by amyloid b peptide [28–30], and pre-
venting kainic acid induced excitotoxicity [31]. Furthermore,
more data showed that RSV improved the impaired learning and
memory in neurodegenerative conditions such as that in AD or
HD models, or cognitive impairment induced by scopolamine or
prenatal stress [32,33]. In this study, we investigated the role of
RSV on learning and memory in normally aged mice. After one-
week treatment of RSV, the locomotor and exploratory activities
of mice were not affected as no any signiﬁcant differences were
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Fig. 2. Resveratrol regulates the plasticity in mouse hippocampus. (A) RSV treatment did not change the evoked fEPSP slope. (B) The amplitude of the evoked fEPSP in RSV
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slice remained potentiated (n = 9 slices, 132.2 ± 7.8% compared with baseline). (D) The elevated effect of RSV on LTP in a SIRT1-dependent manner. Slices from SIRT1D mice
failed to induce LTP under RSV treatment (n = 8 slice, 109.2 ± 10.7% compared with baseline).
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Fig. 3. Resveratrol up-regulates CREB-mediated transcriptional activity (A) RSV
treatment decreased the levels of miR-124 and miR-134 in cultured hippocampus
slice. (B) RSV dose-dependently upregulated CREB-mediated transcriptional activ-
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treated with different concentration RSV for 6-h. Reporter activities are displayed as
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markedly improved freezing behavior as evaluated by the context-
and tone-dependent fear conditioning paradigm (p = 0.027,
p = 0.0199, Fig. 1B) 24-h after training when compared to control
mice. Mechanistically, we investigated whether the latter effect
of RSV is mediated via SIRT1. Such a point is worthy of testing since
there is also evidence that RSV may not be the direct agonist of
SIRT1. The controversy was raised because the assay used by Ho-
witz [19] to screen for small molecule activators of SIRT1 relied
on a ﬂuorescent substrate, and non-ﬂuorescent assays have pro-
duced differing results [34,35]. Nevertheless, our present data indi-
cated that the improved effect on memory of one-week RSV
treatment was mediated by SIRT1 pathway. As shown in Fig. 1C,
RSV did not enhance freezing behavior in SIRT1D mice, in contrast
to control mice, indicating that the effects of RSV on learning and
memory occur through SIRT1. Neither SIRT1 loss-of-function nor
RSV treatment affected shock sensitivity (Fig. 1D). In addition, we
examined whether the acetylation of PGC-1alpha was decreased
following RSV treatment. Indeed, we observed a decrease in PGC-
1alpha acetylation (Fig. 1A), suggesting that SIRT1 activity is in-
creased following one-week RSV treatment. Although it is clear
that the mode of action by RSV on SIRT1 in our system still need
more investigation, the positive effect of RSV on learning and
memory assayed in aged mice are encouraging, as it is consistent
with a large body of literature pointing to the positive metabolic
effects and potential therapeutic beneﬁts of RSV administration.
Furthermore, we used the long-term potentiation (LTP) para-
digm to directly determine the roles of RSV in synaptic plasticity.
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Fig. 4. Resveratrol treatment enhanced the expression levels of CREB and BDNF in
cultured hippocampus slice. (A) CREB protein levels were elevated in the hippo-
campi of RSV mice. Band densities were normalized to GADPH. Representative
Western blots are shown in upper panel. (B) Expression of BDNF protein levels in
the hippocampi of RSV slice was increased compared with Veh mice. Hippocampi
from mice (n = 3 per group) were dissected and subjected to Western blotting, and
optical density is displayed as average ± sem. in the histogram. ⁄⁄p < 0.01.
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slices prepared from control mice subjected to one train of h burst
stimulation (TBS), which is insufﬁcient to generate an LTP response
in 8–9 month-old mice. However, 1-h pretreatment of RSV facili-
tated an LTP response from single train h burst (Fig. 2C). Similar
to the results seen from the functional measurements, RSV did
not facilitate LTP in SIRT1Dmice (Fig. 2D). Furthermore, ﬁeld excit-
atory postsynaptic potential and paired pulse facilitation were not
altered after RSV treatment (Fig. 2A and B), clearly ruling out the
RSV effect of basic transmission. As our previous studies have sug-
gested the role of miRNAs in regulating LTP, we analyzed the levels
several brain speciﬁc miRNAs in RSV-treated hippocampus slices.
Interestingly, the levels of miR-134 and 124 were down-regulated
in RSV treated individuals. MiR-124 is one of the most conserved
and abundantly expressed NS-speciﬁc miRNAs in brain and miR-
134 is a brain-speciﬁc miR [36,37]. Both of them are reported to
regulate CREB expression [22,26,27], which in turn regulates the
activation of immediate early genes that ultimately facilitates syn-
aptic plasticity. Taken together, these data indicate a positive rela-
tionship between RSV treatment and synapse plasticity, which can
in turn impact learning and memory.
By orally administration, RSV is rapidly absorbed and readily
metabolized to form mainly glucuronide and sulfate derivatives
which are eliminated by urine [38,39]. It is generally believed that
the effect of RSV on cell survival can be ambiguous and that itdepends on the doses of RSV. One study analyzing the heart tissue
showed that at lower doses of 2.5 or 5 mg/kg, RSV exerted survival
signal by up-regulating the anti-apoptotic and redox proteins Akt
and Bcl-2, while at higher doses (>25 mg/kg) it potentiated a death
signal by down-regulating redox proteins and upregulating pro-
apoptotic proteins [40]. In this study, we also observed the toxic ef-
fect of RSV at high dose (P50 lM) on cultured neurons or cells
(data not shown). In this regard, it is worth pointing out that
although it is usually considered as an antioxidant, RSV can also
exhibit pro-oxidant properties in the presence of transition metal
ions such as copper, leading to oxidative breakage of cellular
DNA [41]. Thus, while diet-rich antioxidants are generally beneﬁ-
cial for our health, we should still be careful to the dosage and fre-
quency of usage.
Taken together, RSV treatment improved learning and memory
in 8–9 month-old mice through miR-CREB-BDNF pathway. Our
data are consistent with the large body of literature showing that
the RSV-rich diet is generally beneﬁcial for human health, and
additionally suggest a new strategy for therapeutic intervention
of human diseases associated with memory impairment.
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